Featured Speaker:The Proprotein Convertase SUBTILISIN/KEXIN TYPE-9: A Novel Target for Cancer Control
Zoom URL to Join
https://urldefense.proofpoint.com/v2/url?u=https-3A__us06web.zoom.us_j_86728187520-3Fpwd-3DRUtvM244QzBKMGRWQkpxMVpNdXJkdz09&d=DwQFAg&c=27AKQ-AFTMvLXtgZ7shZqsfSXu-Fwzpqk4BoASshREk&r=4du8jn_R93SIU9GkpNMbvYPZCkiCMv2O1zOuV1i4oqg&m=YaHofmp0kDlfvN1WUU_NJ-olY4zumx_cMNf_DvQzcQU&s=PmzkP_MRtVayPKNQwiJ1JZRl2jTxApY-WeHAbA92tiI&e=
Presentation Type
Presentation
Start Date
16-7-2021 9:30 AM
End Date
16-7-2021 9:50 AM
Description
Session Chair: Ayooluwa Aderibigbe, PhD, School of Pharmacy, University of Mississippi
Relational Format
Presentation
Recommended Citation
El Sayed, PhD, Khalid, "Featured Speaker:The Proprotein Convertase SUBTILISIN/KEXIN TYPE-9: A Novel Target for Cancer Control" (2021). Drug Discovery and Development Colloquium. 3.
https://egrove.olemiss.edu/dddc/2021/07-16-2021/3
Featured Speaker:The Proprotein Convertase SUBTILISIN/KEXIN TYPE-9: A Novel Target for Cancer Control
Session Chair: Ayooluwa Aderibigbe, PhD, School of Pharmacy, University of Mississippi
https://egrove.olemiss.edu/dddc/2021/07-16-2021/3